Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Prepaid Assets: 2023-2025

Historic Prepaid Assets for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $13.5 million.

  • CG Oncology's Prepaid Assets rose 20.28% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.5 million, marking a year-over-year increase of 20.28%. This contributed to the annual value of $12.2 million for FY2024, which is 92.07% up from last year.
  • Latest data reveals that CG Oncology reported Prepaid Assets of $13.5 million as of Q3 2025, which was up 18.35% from $11.4 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Prepaid Assets ranged from a high of $13.5 million in Q3 2025 and a low of $6.4 million during Q4 2023.
  • In the last 3 years, CG Oncology's Prepaid Assets had a median value of $11.7 million in 2024 and averaged $11.2 million.
  • Data for CG Oncology's Prepaid Assets shows a peak YoY surged of 92.07% (in 2024) over the last 5 years.
  • CG Oncology's Prepaid Assets (Quarterly) stood at $6.4 million in 2023, then surged by 92.07% to $12.2 million in 2024, then increased by 20.28% to $13.5 million in 2025.
  • Its Prepaid Assets was $13.5 million in Q3 2025, compared to $11.4 million in Q2 2025 and $12.4 million in Q1 2025.